Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Askanase

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug MonitoringShivani Garg, Benoît Blanchet, Yann Nguyen, et al.
Rheumatology (Oxford, England)|September 6, 2015
The frequency and outcome of lupus nephritis: results from an international inception cohort studyJohn G Hanly, Aidan G O'Keeffe, Li Su, et al.
Arthritis Care & Research|October 15, 2019
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model ApproachMegan R W Barber, John G Hanly, Li Su, et al.
Journal of Autoimmunity|October 21, 2019
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosusHelena Enocsson, Lina Wirestam, Charlotte Dahle, et al.
Annals of the Rheumatic Diseases|December 22, 2018
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohortArielle Mendel, Sasha B Bernatsky, John G Hanly, et al.
Arthritis Care & Research|July 26, 2018
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception CohortMay Y Choi, Ann E Clarke, Yvan St Pierre, et al.
Rheumatology (Oxford, England)|February 13, 2019
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogenArielle Mendel, Sasha Bernatsky, Christian A Pineau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2019
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort StudyJohn G Hanly, Qiuju Li, Li Su, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Arthritis Care & Research|December 28, 2021
Evaluating the Construct of Damage in Systemic Lupus ErythematosusSindhu R Johnson, Dafna D Gladman, Hermine I Brunner, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug MonitoringShivani Garg, Benoît Blanchet, Yann Nguyen, et al.
Rheumatology (Oxford, England)|September 6, 2015
The frequency and outcome of lupus nephritis: results from an international inception cohort studyJohn G Hanly, Aidan G O'Keeffe, Li Su, et al.
Arthritis Care & Research|October 15, 2019
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model ApproachMegan R W Barber, John G Hanly, Li Su, et al.
Journal of Autoimmunity|October 21, 2019
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosusHelena Enocsson, Lina Wirestam, Charlotte Dahle, et al.
Annals of the Rheumatic Diseases|December 22, 2018
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohortArielle Mendel, Sasha B Bernatsky, John G Hanly, et al.
Arthritis Care & Research|July 26, 2018
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception CohortMay Y Choi, Ann E Clarke, Yvan St Pierre, et al.
Rheumatology (Oxford, England)|February 13, 2019
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogenArielle Mendel, Sasha Bernatsky, Christian A Pineau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2019
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort StudyJohn G Hanly, Qiuju Li, Li Su, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Arthritis Care & Research|December 28, 2021
Evaluating the Construct of Damage in Systemic Lupus ErythematosusSindhu R Johnson, Dafna D Gladman, Hermine I Brunner, et al.
Pageof 11